Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00409799
Other study ID # CS I-040101/02
Secondary ID
Status Completed
Phase Phase 2
First received December 8, 2006
Last updated March 15, 2012
Start date November 2006
Est. completion date September 2011

Study information

Verified date March 2012
Source Kuros Biosurgery AG
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

For certain tibial plateau fractures the bone is compressed due to the force acting on the tibia during the accident. The void provoked by the compression of the bone is filled with an appropriate filling material and the fracture is fixated. I 0401 is a new bone graft substitute that has shown capacities to promote bone-healing. This study will test the safety and efficacy of I 0401 in the treatment of patients with tibial plateau fractures requiring grafting.


Recruitment information / eligibility

Status Completed
Enrollment 208
Est. completion date September 2011
Est. primary completion date September 2011
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Radiological evidence of a tibial plateau fracture requiring grafting

- Females of child-bearing potential must be willing to undergo a pregnancy test (urine) prior to treatment start (at screening).

Exclusion Criteria:

- Concomitant ipsilateral fractures of the limb other than the fracture of the tibial plateau.

- Active or past history of malignant tumor.

- Evidence of systemic or localized infection at time of surgery.

- Pregnant or lactating females.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
I-0401 (a new bone graft substitute)
1 time application

Locations

Country Name City State
Australia Royal Adelaide Hospital (48) Adelaide South Australia
Australia Gold Coast Hospital (49) Gold Coast Queensland
Australia Princess Alexandra Hospital (45) Woollongabba Queensland
France Hopital La Cavale Blanche (19) Brest
France Hôpital de Dunkerque (30) Dunkerque
France Hôpital Central de Nancy (05) Nancy
France Hôpital Charles Nicolle (15) Rouen
Germany Charite, Campus Virchow Klinikum (03) Berlin
Germany Berufsgenossenschaftliche Unfallklinik Bochum/Duisburg (11) Duisburg
Germany Uniklinik Göttingen (22) Göttingen
Germany Med. Hochschule Hannover (06) Hannover
Germany Universitätsklinikum Schleswig-Holstein (40) Kiel
Germany St.-Josef-Krankenhaus (12) Linnich
Germany Chirurgische Klinik der LMU (50) München
Germany Universitätsklinikum Münster (39) Münster
Hungary Fövarosi Önkormanyzat Karolyi Sandor Korhaz es Rendelointezet (21) Budapest
Hungary Fövarosi Önkormanyzat Peterfy Sandor utcai Korhaz-Rendelöinezet es Baleseti Központ (20) Budapest
Hungary Fovárosi Önkormányzat Szent János Kórháza és Észak (54) Budapest
Hungary Petz Alandar County Teaching Hospital (55) Györ
Hungary Szegedi Egyetem AOK Kari Gyogyszertar (27) Szeged
Italy Istituti Ortopedici Rizzoli (13) Bologna
Italy Fondazione Istituto San Raffaele G. Giglio di Cefalù (16) Cefalù
Italy A.O. Universitaria San Martino (33) Genova
Italy A.O. San Giovanni Oddolorata (14) Roma
Italy Università degli Studi di Roma "Tor Vergata" (10) Roma
Poland Klinika i Oddzial Kliniczny - Ortopedii i Traumatologii (36) Krakow
Poland Oddzial Chirurgii Ortopedyczno-Urazowej - Wojewodzki Szpital Specjalistyczny (58) Lodz
Poland SPZOZ Wojewodzki - Specjalistyczny Szpital Chirurgii Urazowej (35) Piekary Slaskie
Poland Katedra i Klinika Ortopedii - Traumatologii PAM (34) Szczecin
Poland Wojskowy Instytut Medyczny - Centralny Szpital Kliniczny MON (60) Warsaw
Poland Katedra I Klinika Ortopedii AM (29) Warszawa
Spain Hospital FREMAP Majadahonda (17) Madrid
Spain Hospital Universitario de la Princesa (18) Madrid
Spain Hospital Universitario Virgen de la Victoria (51) Málaga
Spain Hospital FREMAP Sevilla (32) Sevilla
Spain Hospital Universitario La Fe (07) Valencia
Switzerland Universitätsspital Basel (24) Basel
Switzerland Kantonsspital Bruderholz (25) Bruderholz
Switzerland CHUV Lausanne (02) Lausanne
Switzerland Kantonsspital Luzern (26) Luzern
Switzerland Zurich University Hospital (01) Zurich Canton Zurich
United Kingdom N. Bristol NHS Trust + Univ. of Bristol (52) Bristol
United Kingdom University Hospital of Wales (31) Cardiff
United Kingdom Leeds General Infirmary (04) Leeds West Yorkshire
United Kingdom Norfolk and Norwich University Hospital (44) Norwich

Sponsors (1)

Lead Sponsor Collaborator
Kuros Biosurgery AG

Countries where clinical trial is conducted

Australia,  France,  Germany,  Hungary,  Italy,  Poland,  Spain,  Switzerland,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Radiographic Images All Follow-Up Visits
Secondary Clinical assessments of the fracture site All Follow-Up Visits
Secondary Blood parameters All Follow-Up Visits
Secondary Vital signs At several Follow-Up visits
Secondary Questionnaires of Life All Follow-Up Visits
Secondary Pharmacoeconomic evaluation All Follow-Up Visits